STRATA Skin Sciences - SSKN Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $3.80
  • Forecasted Upside: 927.03%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.37
▼ -0.01 (-2.63%)

This chart shows the closing price for SSKN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New STRATA Skin Sciences Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SSKN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SSKN

Analyst Price Target is $3.80
▲ +927.03% Upside Potential
This price target is based on 0 analysts offering 12 month price targets for STRATA Skin Sciences in the last 3 months. The average price target is $3.80, with a high forecast of $3.80 and a low forecast of $3.80. The average price target represents a 927.03% upside from the last price of $0.37.

This chart shows the closing price for SSKN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in STRATA Skin Sciences. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/30/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/25/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/23/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/23/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/23/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/10/2023LADENBURG THALM/SH SHLower Target$4.10 ➝ $3.80N/A
11/15/2022OppenheimerLower Target$2.00Low
11/3/2020HC WainwrightUpgradeNeutral ➝ Buy$3.00High
8/12/2020LADENBURG THALM/SH SHReiterated RatingBuy$3.75High
8/11/2020HC WainwrightReiterated RatingHoldMedium
8/11/2020OppenheimerReiterated RatingBuy$6.00Medium
5/12/2020HC WainwrightReiterated RatingHoldMedium
5/12/2020OppenheimerReiterated RatingBuy$6.00High
4/20/2020HC WainwrightReiterated RatingHoldLow
3/17/2020HC WainwrightDowngradeBuy ➝ NeutralHigh
12/9/2019LADENBURG THALM/SH SHInitiated CoverageBuy$5.25High
11/20/2019OppenheimerInitiated CoverageOutperform$7.00Low
9/16/2019HC WainwrightReiterated RatingBuyHigh
7/8/2019HC WainwrightSet TargetBuy$5.00Low
(Data available from 5/23/2019 forward)

News Sentiment Rating

0.16 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/26/2023
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/25/2023
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/25/2023
  • 5 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/24/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/23/2024
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/24/2024
  • 1 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/23/2024
  • 2 very positive mentions
  • 23 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/23/2024

Current Sentiment

  • 2 very positive mentions
  • 23 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
STRATA Skin Sciences logo
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
Read More

Today's Range

Now: $0.37
Low: $0.37
High: $0.38

50 Day Range

MA: $0.46
Low: $0.38
High: $0.56

52 Week Range

Now: $0.37
Low: $0.26
High: $1.08

Volume

152,658 shs

Average Volume

32,148 shs

Market Capitalization

$12.97 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.53

Frequently Asked Questions

What sell-side analysts currently cover shares of STRATA Skin Sciences?

The following Wall Street research analysts have issued stock ratings on STRATA Skin Sciences in the last twelve months: LADENBURG THALM/SH SH.
View the latest analyst ratings for SSKN.

What is the current price target for STRATA Skin Sciences?

1 Wall Street analysts have set twelve-month price targets for STRATA Skin Sciences in the last year. Their average twelve-month price target is $3.80, suggesting a possible upside of 900.0%. LADENBURG THALM/SH SH has the highest price target set, predicting SSKN will reach $3.80 in the next twelve months. LADENBURG THALM/SH SH has the lowest price target set, forecasting a price of $3.80 for STRATA Skin Sciences in the next year.
View the latest price targets for SSKN.

What is the current consensus analyst rating for STRATA Skin Sciences?

STRATA Skin Sciences currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for SSKN.

What other companies compete with STRATA Skin Sciences?

How do I contact STRATA Skin Sciences' investor relations team?

STRATA Skin Sciences' physical mailing address is 5 WALNUT GROVE DRIVE SUITE 140, HORSHAM PA, 19044. The medical device company's listed phone number is (215) 619-3200 and its investor relations email address is [email protected]. The official website for STRATA Skin Sciences is www.strataskinsciences.com. Learn More about contacing STRATA Skin Sciences investor relations.